Rekha Hemrajani - Jun 18, 2025 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Role
Director
Signature
/s/ David Sandoval, Attorney-in-Fact
Stock symbol
MXCT
Transactions as of
Jun 18, 2025
Transactions value $
$0
Form type
4
Date filed
6/23/2025, 06:43 PM
Previous filing
Jun 9, 2025
Next filing
Aug 27, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hemrajani Rekha Director C/O MAXCYTE, INC., 9713 KEY WEST AVENUE, SUITE 400, ROCKVILLE /s/ David Sandoval, Attorney-in-Fact 2025-06-23 0001771213

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXCT Common Stock Award $0 +29.2K +136.71% $0.00 50.6K Jun 18, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Stock Option (right to buy) Award $0 +50.8K $0.00 50.8K Jun 18, 2025 Common Stock 50.8K $2.11 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 18, 2026, subject to the reporting person's continuous service as of such vesting date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney